Results 121 to 130 of about 59,932 (250)

Retrospective study and outcome of 307 cats with feline infectious peritonitis treated with legally sourced veterinary compounded preparations of remdesivir and GS-441524 (2020–2022)

Journal of feline medicine and surgery, 2023
Objectives Feline infectious peritonitis (FIP) is a serious disease that arises due to feline coronavirus infection. The nucleoside analogues remdesivir and GS-441524 can be effective in its treatment, but most studies have used unregulated products of ...
S. Taylor, Sally Coggins, E. N. Barker, Danièlle Gunn-Moore, K. Jeevaratnam, Jacqueline M Norris, David Hughes, E. Stacey, Laura MacFarlane, Carolyn R. O'Brien, R. Korman, G. McLauchlan, Xavier Salord Torres, Aimee Taylor, Jos Bongers, Laura Espada Castro, Max Foreman, James McMurrough, Bethany Thomas, Emilie Royaux, I. Calvo Saiz, Guido Bertoldi, Caroline Harlos, M. Work, C. Prior, Stephanie Sorrell, Richard Malik, Séverine Tasker   +27 more
semanticscholar   +1 more source

Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study

Transplant Infectious Disease, EarlyView.
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon, Merle Sophie Kaiser, Marcus Bachmann, Gérard Krause, Jens Gottlieb   +4 more
wiley   +1 more source

Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report

Journal of Pharmaceutical Health Care and Sciences
Background Remdesivir is recommended to treat hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is known to affect glucose metabolism in individuals with and without diabetes.
Yasunori Nagano, Hisae Aoki, Juri David, Naoko Iwahashi Kondo, Makimi Aizawa, Toshiyuki Sumita, Yuki Hamada, Yuki Yamamoto, Kaoru Yamada   +8 more
doaj   +1 more source

Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice

Frontiers in Pharmacology, 2021
Pulmonary fibrosis is a known sequela of severe or persistent lung damage. Existing clinical, imaging and autopsy studies have shown that the lungs exhibit a pathological pulmonary fibrosis phenotype after infection with coronaviruses, including severe ...
Xiaohe Li, Xiaohe Li, Rui Liu, Rui Liu, Yunyao Cui, Yunyao Cui, Jingjing Liang, Jingjing Liang, Zhun Bi, Shimeng Li, Shimeng Li, Yang Miao, Liang Zhang, Xiaoping Li, Honggang Zhou, Honggang Zhou, Cheng Yang, Cheng Yang   +17 more
doaj   +1 more source

Temporal Trends in Physician Burnout During and After the COVID‐19 Pandemic in Japan: A Repeated Cross‐Sectional Study

Journal of General and Family Medicine, Volume 27, Issue 2, March 2026.
ABSTRACT Background To examine how burnout among Japanese internists and primary care physicians evolved from the onset of the coronavirus disease‐2019 (COVID‐19) pandemic to the post‐pandemic period. Methods We reanalyzed data from five web‐based surveys of members of the American College of Physicians—Japan Chapter between January 2020 and April 2024.
Akira Kuriyama, Kiyoshi Shikino
wiley   +1 more source

Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review

Journal of Infection and Public Health, 2021
The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries, including Saudi Arabia, since 2020. The generic structure of remdesivir was first disclosed in 2009.
Mohd. Imran, Ahmed Subeh Alshrari, Syed Mohammed Basheeruddin Asdaq, Abida   +3 more
doaj   +1 more source

Are Tetrapleura tetraptera Phytochemicals Druggable Against SARS‐CoV‐2 Papain‐Like Protein? A Computational Approach

New Zealand Journal of Botany, Volume 64, Issue 1, March 2026.
SARS‐CoV2 Omicron and its substrains are still a critical global health issue and extremely contagious, even with widespread vaccination efforts. Hospitalizations and mortality rates linked to these variants are still prevalent. Current therapeutic options face challenges, including low effectiveness, suboptimal pharmacokinetics, and drug resistance ...
Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu   +1 more
wiley   +1 more source

Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

Infectious Diseases of Poverty, 2023
Background Remdesivir is being studied and used to treat coronavirus disease 2019 (COVID-19). This study aimed to systematically identify, critically evaluate, and summarize the findings of the studies on the cost-effectiveness of remdesivir in the ...
Aziz Rezapour, Zahra Behroozi, Mostafa Nasirzadeh, Mohsen Rezaeian, Mohammad Barzegar, Mahsa Tashakori-Miyanroudi, Abdollah Sayyad, Aghdas Souresrafil   +7 more
doaj   +1 more source

Thirty‐two cats with effusive or non‐effusive feline infectious peritonitis treated with a combination of remdesivir and GS‐441524

Journal of Veterinary Internal Medicine, 2023
Background GS‐441524 has been successfully used to treat feline infectious peritonitis (FIP) in cats. However, the use of its prodrug, remdesivir, in combination with a PO GS‐441524 containing product for the treatment of FIP has not yet been described ...
Jodie Green, H. Syme, S. Tayler
semanticscholar   +1 more source

Investigation of Teratogenic Concerns in the Coronavirus Disease of 2019 Era

Birth Defects Research, Volume 118, Issue 2, February 2026.
ABSTRACT Background MotherToBaby (MTB) is a teratogen information service that provides information about exposures during pregnancy and breastfeeding to the public and healthcare providers. During the Coronavirus Disease of 2019 (COVID‐19) pandemic, MTB received an influx of queries regarding the teratogenicity of the virus and the vaccine.
Kate Richardson, Emily C. Daykin, Kathleen Shields, S. Shahrukh Hashmi, Lorrie Harris‐Sagaribay, Molly Daniels, Myla Ashfaq   +6 more
wiley   +1 more source